Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. M.C.A. Kramer

Publicaties

Correction: Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study (Cancers, (2025), 17, 15, (2425), 10.3390/cancers17152425)

Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425.

Assessing the Validity of Diffusion Weighted Imaging Models: A Study in Patients with Post-Surgical Lower-Grade Glioma

Deep Learning for Automated Ventricle and Periventricular Space Segmentation on CT and T1CE MRI in Neuro-Oncology Patients

Distinguishing Mental From Physical Fatigue in Patients With Low-Grade Glioma

DSC Perfusion MRI Artefact Reduction Strategies: A Short Overview for Clinicians and Scientific Applications

Effects of radiotherapy on synaptic density as assessed by [11C]UCB-J PET in the brains of patients with head and neck cancer

Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma – The Dutch approach

Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study

Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study

Pers/media

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology